Wolframin (WFS1) (WFS1)

Wolframin is an 890-amino acid transmembrane protein primarily localized to the endoplasmic reticulum (ER) [1, 12]. It plays a critical role in maintaining cellular homeostasis by regulating ER calcium levels and the unfolded protein response (UPR) [1, 10]. Wolframin is highly expressed in the pancreas, brain, and heart, where it supports functions such as insulin secretion and neuronal survival [1, 17]. Mutations in the WFS1 gene lead to Wolfram syndrome, a rare neurodegenerative disorder characterized by juvenile-onset diabetes mellitus, optic atrophy, and deafness [1, 12]. At the molecular level, wolframin acts as a regulator of ER-mitochondria communication and protects cells from ER stress-induced apoptosis [4, 6]. Loss of function results in calcium dyshomeostasis and chronic ER stress, particularly in pancreatic beta cells and neurons [1, 2]. While no direct wolframin-targeting drugs are currently approved, therapeutic strategies focus on repurposing ER calcium stabilizers like dantrolene, chemical chaperones like PBA/TUDCA, and GLP-1 receptor agonists to mitigate the downstream effects of wolframin deficiency [2, 11, 15].

Other names

WFS1CTRCT41WFRSWFSWFSLWolfram syndrome 1 proteinWolframin ER transmembrane glycoprotein

ER calcium stabilization, mitigation of ER stress, restoration of calcium signaling, prevention of apoptosis, and chemical chaperone activity [1, 2, 3, 5, 13]